Triple-Negative Breast Carcinoma — Trials

Triple-Negative Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

950 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 417
Recruiting: 234
Ph III recruiting: 22
Growth YoY: +2.4%
Industry share: 31%
Top sponsor: Fudan University
Termination share: 47.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (168)

clinicaltrialsPublishedShowing 101–102 of 102 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00951054	A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer	completed	Phase 2	61	Nippon Kayaku Co., Ltd.INDUSTRY	1	Feb 16, 2015	clinicaltrials
NCT01969032	Induction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast Cancer	completed	Phase 2	41	Russian Academy of Medical SciencesOTHER	1	Nov 5, 2014	clinicaltrials